Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream

Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream
esagonowsky
Fri, 06/11/2021 – 10:17